dr. tam on the combination of ibrutinib plus venetoclax in mantle cell lymphoma
Published 7 years ago • 264 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
1:08
dr. tam on the toxicities of ibrutinib plus venetoclax in mcl
-
1:08
dr. tam on the toxicity of ibrutinib plus venetoclax in mcl
-
1:02
dr. tam on zanubrutinib vs ibrutinib research in mantle cell lymphoma
-
1:27
dr. rule on the combination of venetoclax and ibrutinib in mcl
-
2:00
preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
-
1:22
dr. kaplan on the combination of ibrutinib and venetoclax in mcl
-
1:09
dr. ritchie on the immunologic impact of long-term venetoclax/ibrutinib in r/r mcl
-
1:32
dr. kahl on findings from the l-mind study with tafasitamab in dlbcl
-
0:48
dr. martin on the role of transplant in mantle cell lymphoma
-
0:58
dr. leslie on the benefits with zanubrutinib in mcl
-
1:22
dr. leslie on sequencing zanubrutinib in mcl
-
0:44
dr. tam on zanubrutinib approval in mcl
-
1:01
dr. kolibaba on entospletinib activity in mantle cell lymphoma
-
2:46
ibrutinib venetoclax treatment for mantle cell lymphoma | constantine tam, md, mbbs | ash 2023
-
2:06
the role of venetoclax in r/r mcl & options for patients who progress on venetoclax
-
3:18
sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
-
1:33
dr. jacobs on the efficacy of ibrutinib and acalabrutinib in patients with mcl
-
2:22
dr. leslie on the development of car t-cell therapy in dlbcl and mcl
-
1:27
dr. patel on induction in patients with mantle cell lymphoma